Review
Copyright ©The Author(s) 2016.
World J Gastroenterol. Sep 28, 2016; 22(36): 8078-8093
Published online Sep 28, 2016. doi: 10.3748/wjg.v22.i36.8078
Figure 1
Figure 1 Simplified cartoon of the multiple pathomechanisms involved in development and progression of non-alcoholic fatty liver disease, and proposed stepwise treatment options. NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steato-hepatitis; FXR: Farnesoid X receptor; AT: Adipose tissue.